Navigation Links
BioCryst Provides Update Regarding Peramivir for Influenza
Date:9/30/2009

formance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: that peramivir may not receive emergency use authorization; that the U.S. government and ex-U.S. governments may choose not to issue a request for peramivir to treat influenza or such requests, if any, may not result in an order or such order, if any, may not be profitable for BioCryst; that to the extent peramivir is used as a treatment for H1N1 flu (or other strains of flu), there can be no assurance that it will prove effective; that HHS may further condition, reduce or eliminate future funding of the peramivir program; that ongoing peramivir clinical trials or our peramivir program in general may not be successful; that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates; that our product candidates may not receive required regulatory clearances from the FDA; that ongoing and future pre-clinical and clinical development may not have positive results; that we or our licensees may not be able to continue future development of our current and future development programs; that our development programs and partnerships may never result in future product, license or royalty payments being received by BioCryst; that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates; that our actual ca
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
2. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
3. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
4. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
5. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
6. BioCryst Updates Peramivir Clinical Development Plan
7. BioCryst Provides Forodesine HCl Update
8. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
9. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
10. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
11. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2014 on Thursday, July 31, 2014, after the ... and chief executive officer, will host a conference call to ... p.m. Pacific Time (PT). The press release ... be accessed through a link that is posted on the ...
(Date:7/22/2014)... July 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: ... 2014 financial results after the market closes on Tuesday, ... webcast will be held on Tuesday, August 5, 2014, ... To participate in the call, please dial ... A rebroadcast of the teleconference will be available for ...
(Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
... Permanente leads the nation among all reporting commercial health ... conclusions were based on information in the 2010 National ... Kaiser Permanente received top marks for: ... Appropriate treatment for children with upper respiratory infection ...
... 11 More than 170 industry experts and thought ... executive workshops at AdvaMed 2010: The MedTech Conference ... fourth year, this annual medical technology industry developed and ... and around the world.   "This conference ...
Cached Medicine Technology:Kaiser Permanente Leads the Nation in 12 Quality Measures 2Kaiser Permanente Leads the Nation in 12 Quality Measures 3Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010 2Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010 3
(Date:7/23/2014)... --- Controlling pain during childbirth and post delivery may ... M.D., a Northwestern Medicine perinatal psychiatrist, in a July ... , Wisner,s editorial is based on a new Chinese ... epidural anesthesia during a vaginal delivery had a much ... have the epidural. , "Maximizing pain control in labor ...
(Date:7/22/2014)... Kansas City, MO (PRWEB) July 22, 2014 ... cheap Sporting Kansas City vs. Manchester City tickets at ... match will take place on Wednesday, July 23rd. Tickets ... up to game time. Ticket Down can be reached ... City vs. Manchester City are authentic and covered by Ticket ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 As ... products for consumers to buy can now reduce or ... News company has released its cosmetic buying guide to ... eyes at http://cherrynews.com/best-nourishing-eye-serum . , This guide is ... suffer from the different under eye circles that can ...
(Date:7/22/2014)... July 22, 2014 DocbookMD , ... of deploying one of the largest physician-centric mobile communication ... MHMD ) in Houston. , Created by Austin-based physicians, ... DocbookMD application will be embedded into MHMD’s Accountable Care ... for the best technology to put this capability at ...
(Date:7/22/2014)... Beach, FL (PRWEB) July 22, 2014 ... that they are now an authorized Daikin comfort pro ... and install Daikin indoor heating and cooling system equipment. ... each one is thoroughly reviewed before being approved. , ... an innovator in the Split System Air Conditioning Market. ...
Breaking Medicine News(10 mins):Health News:Controlling childbirth pain tied to lower depression risk 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2
... Toy Puppies to the Obama Daughters , , ... President-Elect Obama,s first promise: to get a family dog. But ... kept the new first-dad from making a decision. So, in ... donating 2 "asthma & allergy friendly" toy puppies to the Obama ...
... with imaging exam results may enable a more meticulous ... as a more personal and empathetic approach, according to ... the Radiological Society of North America (RSNA). , ... being and not as an anonymous case study," said ...
... the connection between second-hand smoke and coronary heart disease ... such passive smoking, exposures have been reduced. In an ... American Journal of Preventive Medicine , researchers from ... and Columbia University have recalibrated the CHD Policy Model ...
... Ensign Group, Inc.,(Nasdaq: ENSG ) announced that ... successfully graduated from the Centers for Medicare and,Medicaid Services, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , ... Laurie House, Director of Nursing at Pocatello Care,& Rehabilitation ...
... the face of one of the most,severe economic downturns ... of,Directors has approved an investment of up to a ... Employee pension plans, which are,often heavily invested in stocks ... nation,s worsening economy. Although conservatively,invested, the Sutter Health Retirement ...
... of higher mortality and lower surgery rates in women ... may be related to the complexity of evaluating the ... Mayo Clinic study published this month in the ... affects approximately 150 million people worldwide and often requires ...
Cached Medicine News:Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:Patient photos spur radiologist empathy and eye for detail 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 3Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:Women with mitral valve prolapse are treated less aggressively than men and may be at high risk 2
... patient ID verification and laboratory specimen labeling system ... the phlebotomist or nurse, the identity of the ... verification is made, a bar coded sample ID ... unique design simplifies and eliminates the interface problems ...
... Horizon Admin-Rx is a bar-code medication administration ... medication administration process with bar-code technology. Caregivers ... handheld or laptop device to verify that ... at the right time in the right ...
... MedPoint™, a Medication Administration Control ... positive assurance that they are administering ... When used with a bar coded ... MedPoint extends the benefits of the ...
... When it comes to medication administration, ... afford to make. The solution is the ... a highly-scalable bar-coded medication administration system, suitable ... also be used stand-alone, networked, or as ...
Medicine Products: